InfuSystem Holdings, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Revenue (Tables)

12 Months Ended

Dec. 31, 2024

The following table presents the Company’s disaggregated revenue by offering type (in thousands):


	Years Ended December 31,
	2024				2023
	Total Net Revenues		% of Total Net Revenues		Total Net Revenues		% of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	2,706	2.0	%	$	2,294	1.8	%
Third-Party Payer products	15,023		11.1	%	13,821		11.0	%
Patient Services revenue recognized over time:
Direct rental services	7,683		5.7	%	7,388		5.9	%
Third-Party Payer rental services	47,394		35.1	%	44,475		35.4	%
Total Patient Services accounted for under ASC 606	72,806		53.9	%	67,978		54.1	%
Device Solutions revenue recognized at a point in time:
Products	16,552		12.3	%	14,877		11.8	%
Services	8,861		6.6	%	9,844		7.8	%
Device Solutions revenue recognized over time:
Services	8,082		6.0	%	6,038		4.8	%
Total Device Solutions accounted for under ASC 606	33,495		24.9	%	30,759		24.4	%
Total Revenue Accounted for under ASC 606	106,301		78.8	%	98,737		78.5	%
Patient Services Lease Revenue	7,572		5.6	%	8,563		6.8	%
Device Solutions Lease Revenue	20,988		15.6	%	18,485		14.7	%
Total Revenue accounted for under ASC 842	28,560		21.2	%	27,048		21.5	%
Total Net Revenue	$	134,861	100.0	%	$	125,785	100.0	%